CystoSmart running on the ISC 100: Urology Al that works beside any cystoscopy tower ...
Updated data from TeLuRide-005, an ongoing open-label Phase 2 trial of EIK1001, a TLR7/8 dual-agonist, plus pembrolizumab and histology-appropriate chemotherapy in stage 4 non-small cell lung cancer ...
Please register for the event on the Events and Presentations page of Disc’s website at https://ir.discmedicine.com. A replay of the webcast will be made available on the website following the call.
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...
K2 Vision has performed 5,000 Light Adjustable Lens (LAL) procedures. RxSight, the company that makes the lens, has recognized K2 Vision as the highest-volume LAL practice in the world. The Light ...
"Our mission has always been to provide compassionate, personalized care in a setting where patients feel heard and respected," Dr. Youtsos added. "Having a dermatology-certified nurse practitioner on ...
Phentolamine ophthalmic solution 0.75% is marketed in the United States as RYZUMVI ® for the treatment of pharmacologically induced mydriasis. The supplemental approval expands its approved ...
TIME Best Inventions Recognition: Nanox selected as one of TIME’s Best Inventions of 2026 for its Nanox.ARC X. Nanox.ARC X recognized among the “world’s most groundbreaking innovations” and for its ...
TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and ...
At this year's meeting, Integra will showcase its growing portfolio of ENT technologies and instruments, including the ACCLARENT AERA® Eustachian Tube Treatment, TruDi® Navigation System, MicroFrance® ...
The latest 600-participant study adds to Bacomind's clinical evidence, with findings reported by Natural Remedies indicating potential benefits for memory and cognitive function. The research may help ...
Company to host PDAC focused investor webcast on Friday, October 23, 2026, 7:30 am ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results